Cite
Carbamazepine: a 'blind' assessment of CYP-associated metabolism and interactions in human liver-derived in vitro systems.
MLA
Pelkonen, O., et al. “Carbamazepine: A ‘Blind’ Assessment of CYP-Associated Metabolism and Interactions in Human Liver-Derived in Vitro Systems.” Xenobiotica, vol. 31, no. 6, June 2001, pp. 321–43. EBSCOhost, https://doi.org/10.1080/00498250110055479.
APA
Pelkonen, O., Myllynen, P., Taavitsainen, P., Boobis, A. R., Watts, P., Lake, B. G., Price, R. J., Renwick, A. B., Gómez-Lechón, M.-J., Castell, J. V., Ingelman-Sundberg, M., Hidestrand, M., Guillouzo, A., Corcos, L., Goldfarb, P. S., & Lewis, D. F. V. (2001). Carbamazepine: a “blind” assessment of CYP-associated metabolism and interactions in human liver-derived in vitro systems. Xenobiotica, 31(6), 321–343. https://doi.org/10.1080/00498250110055479
Chicago
Pelkonen, O., P. Myllynen, P. Taavitsainen, A. R. Boobis, P. Watts, B. G. Lake, R. J. Price, et al. 2001. “Carbamazepine: A ‘Blind’ Assessment of CYP-Associated Metabolism and Interactions in Human Liver-Derived in Vitro Systems.” Xenobiotica 31 (6): 321–43. doi:10.1080/00498250110055479.